Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain.
暂无分享，去创建一个
E. Perez | E. Mittendorf | K. Ballman | C. Calfa | D. Northfelt | M. Pegram | K. Knutson | C. Erskine | N. Norton | R. Clynes | W. Tan | K. Tenner | P. Yeramian | Barath Shreeder | Kathleen P. Kemp | B. Shreeder